RxDoctor Payments Data

Mary Johnson, DO

Family Medicine · Troy, ALNPI 1356978563

Payments from drug & device makers

$1,105in general payments, 2019–2025

Across 69 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$178
  • Novo Nordisk$150
  • AstraZeneca$138
  • Amgen$136
  • Astellas Pharma US Inc$75
  • GSK$54
  • plus $374 from 13 others

What the payments were for

  • Food & beverage$1,105100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,105 in reported general payments places this provider in the 55th percentile of 1,680 family medicine providers in Alabama.

See all family medicine providers in Alabama

Medicare billing

Part B allowed, 2024
$5,892
Medicare patients
35
Services billed
78

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban20$13,644
JardianceEmpagliflozin11$11,811
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,509
LinzessLinaclotide11$8,343
XareltoRivaroxaban12$6,808
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,136
Breo ElliptaFluticasone/Vilanterol11$4,650
Lantus SolostarInsulin Glargine,hum.Rec.Anlog23$2,488
Donepezil Hcl118$2,348
Memantine Hcl65$1,999
Atorvastatin Calcium136$1,860
Amlodipine Besylate157$1,745
Levothyroxine Sodium126$1,529
Losartan Potassium80$1,407
Azelastine Hcl32$1,375

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$54$19,29637 claims
AbbVieLinzess$30$8,34311 claims
Johnson & JohnsonXarelto$15$6,80812 claims
Lilly USA, LLCOlanzapine$178$86036 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,680 family medicine providers in Alabama.

Other family medicine in Troy

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →